APO Research
Talk to an analyst

APO RESEARCH · REPORT

Influenza Diagnostics

Influenza is an infectious disease and affects the upper respiratory tract in humans. The disease is common in children and elderly population (aged 65 years and above). The disease has a huge impact on Public Company health. Influenza A virus poses a greater risk as compared to the influenza B virus. The B virus is responsible for 20% to 25% of infections globally. Proper collection, storage and transport of respiratory specimens are the essential first step for laboratory detection of influenza virus infections. Laboratory confirmation of influenza virus from throat, nasal and nasopharyngeal secretions or tracheal aspirate or washings is commonly performed using direct antigen detection, virus isolation, or detection of influenza-specific RNA by reverse transcriptase-polymerase chain reaction (RT-PCR).

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Influenza is an infectious disease and affects the upper respiratory tract in humans. The disease is common in children and elderly population (aged 65 years and above). The disease has a huge impact on Public Company health. Influenza A virus poses a greater risk as compared to the influenza B virus. The B virus is responsible for 20% to 25% of infections globally. Proper collection, storage and transport of respiratory specimens are the essential first step for laboratory detection of influenza virus infections. Laboratory confirmation of influenza virus from throat, nasal and nasopharyngeal secretions or tracheal aspirate or washings is commonly performed using direct antigen detection, virus isolation, or detection of influenza-specific RNA by reverse transcriptase-polymerase chain reaction (RT-PCR).

Selected research

Market Structure

Global Influenza Diagnostics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

22 December 2025194 pages

Choose your research edition.

Industry ResearchInfluenza Diagnostics Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Influenza Diagnostics Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Influenza Diagnostics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Influenza Diagnostics Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Influenza Diagnostics Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

Influenza is an infectious disease and affects the upper respiratory tract in humans. The disease is common in children and elderly population (aged 65 years and above). The disease has a huge impact on Public Company health. Influenza A virus poses a greater risk as compared to the influenza B virus. The B virus is responsible for 20% to 25% of infections globally. Proper collection, storage and transport of respiratory specimens are the essential first step for laboratory detection of influenza virus infections. Laboratory confirmation of influenza virus from throat, nasal and nasopharyngeal secretions or tracheal aspirate or washings is commonly performed using direct antigen detection, virus isolation, or detection of influenza-specific RNA by reverse transcriptase-polymerase chain reaction (RT-PCR).

North America is the largest consumption place, with a consumption marker share nearly 53%. Following North America, Europe is the second largest consumption place with the consumption market share of 25%.

The main manufacturers are BD, Abbott (Include Alere), Roche, SIEMENS, Analytik Jena, Quidel, Thermo Fisher, Meridian Bioscience, BioMerieux, Sekisui Diagnostics, Response Biomedical, SA Scientific etc. BD is the largest manufacturer with about 19% market share.

Read the full market overview

Report Includes

This report provides an overview of the global Influenza Diagnostics market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Influenza Diagnostics and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Influenza Diagnostics revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Influenza Diagnostics market size, projected growth trends, production technologies, key applications, and end-use industries.

Influenza Diagnostics Segment by Company

BD

Abbott (Include Alere)

Roche

SIEMENS

Analytik Jena

Quidel

Thermo Fisher

Meridian Bioscience

BioMerieux

Sekisui Diagnostics

Response Biomedical

SA Scientific

Influenza Diagnostics Segment by Type

RIDT

RT-PCR

Cell Culture

Others

Influenza Diagnostics Segment by Application

Hospitals

POCT

Others

Influenza Diagnostics Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Influenza Diagnostics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Influenza Diagnostics and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Influenza Diagnostics.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Influenza Diagnostics in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Influenza Diagnostics industry.

Chapter 3: Detailed analysis of Influenza Diagnostics companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Influenza Diagnosticsrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Influenza Diagnostics Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of RIDT Table 3. Key Players of RT-PCR Table 4. Key Players of Cell Culture Table 3. Key Players of Others Table 4. Global Influenza Diagnostics Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Hospitals Table 6. Key Players of POCT Table 7. Key Players of Others Table 8. Global Influenza Diagnostics Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 9. Global Influenza Diagnostics Market Size by Region (2021-2026) & (US$ Million) Table 10. Global Influenza Diagnostics Market Share by Region (2021-2026) Table 11. Global Influenza Diagnostics Market Size by Region (2027-2032) & (US$ Million) Table 12. Global Influenza Diagnostics Market Share by Region (2027-2032) Table 13. Influenza Diagnostics Industry Trends Table 14. Influenza Diagnostics Industry Drivers Table 15. Influenza Diagnostics Industry Opportunities and Challenges Table 16. Influenza Diagnostics Industry Restraints Table 17. Global Influenza Diagnostics Revenue by Company (US$ Million) & (2021-2026) Table 18. Global Influenza Diagnostics Revenue Market Share by Company (2021-2026) Table 19. Global Influenza Diagnostics Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 20. Global Influenza Diagnostics Key Company Head Office and Area Served Table 21. Global Influenza Diagnostics Company, Product Type & Application Table 22. Global Influenza Diagnostics Company Establishment Date Table 23. Global Company Market Concentration Ratio (CR5 and HHI) Table 24. Global Influenza Diagnostics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 25. Global Influenza Diagnostics Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Influenza Diagnostics Market Size by Type (2021-2026) & (US$ Million) Table 27. Global Influenza Diagnostics Market Size by Type (2027-2032) & (US$ Million) Table 28. Global Influenza Diagnostics Revenue Market Share by Type (2021-2026) Table 29. Global Influenza Diagnostics Revenue Market Share by Type (2027-2032) Table 30. Global Influenza Diagnostics Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Influenza Diagnostics Market Size by Application (2021-2026) & (US$ Million) Table 32. Global Influenza Diagnostics Market Size by Application (2027-2032) & (US$ Million) Table 33. Global Influenza Diagnostics Revenue Market Share by Application (2021-2026) Table 34. Global Influenza Diagnostics Revenue Market Share by Application (2027-2032) Table 35. BD Company Information Table 36. BD Business Overview Table 37. BD Influenza Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. BD Influenza Diagnostics Product Portfolio Table 39. BD Recent Development Table 40. Abbott (Include Alere) Company Information Table 41. Abbott (Include Alere) Business Overview Table 42. Abbott (Include Alere) Influenza Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Abbott (Include Alere) Influenza Diagnostics Product Portfolio Table 44. Abbott (Include Alere) Recent Development Table 45. Roche Company Information Table 46. Roche Business Overview Table 47. Roche Influenza Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Roche Influenza Diagnostics Product Portfolio Table 49. Roche Recent Development Table 50. SIEMENS Company Information Table 51. SIEMENS Business Overview Table 52. SIEMENS Influenza Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. SIEMENS Influenza Diagnostics Product Portfolio Table 54. SIEMENS Recent Development Table 55. Analytik Jena Company Information Table 56. Analytik Jena Business Overview Table 57. Analytik Jena Influenza Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Analytik Jena Influenza Diagnostics Product Portfolio Table 59. Analytik Jena Recent Development Table 60. Quidel Company Information Table 61. Quidel Business Overview Table 62. Quidel Influenza Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Quidel Influenza Diagnostics Product Portfolio Table 64. Quidel Recent Development Table 65. Thermo Fisher Company Information Table 66. Thermo Fisher Business Overview Table 67. Thermo Fisher Influenza Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. Thermo Fisher Influenza Diagnostics Product Portfolio Table 69. Thermo Fisher Recent Development Table 70. Meridian Bioscience Company Information Table 71. Meridian Bioscience Business Overview Table 72. Meridian Bioscience Influenza Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. Meridian Bioscience Influenza Diagnostics Product Portfolio Table 74. Meridian Bioscience Recent Development Table 75. BioMerieux Company Information Table 76. BioMerieux Business Overview Table 77. BioMerieux Influenza Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. BioMerieux Influenza Diagnostics Product Portfolio Table 79. BioMerieux Recent Development Table 80. Sekisui Diagnostics Company Information Table 81. Sekisui Diagnostics Business Overview Table 82. Sekisui Diagnostics Influenza Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. Sekisui Diagnostics Influenza Diagnostics Product Portfolio Table 84. Sekisui Diagnostics Recent Development Table 85. Response Biomedical Company Information Table 86. Response Biomedical Business Overview Table 87. Response Biomedical Influenza Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 88. Response Biomedical Influenza Diagnostics Product Portfolio Table 89. Response Biomedical Recent Development Table 90. SA Scientific Company Information Table 91. SA Scientific Business Overview Table 92. SA Scientific Influenza Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 93. SA Scientific Influenza Diagnostics Product Portfolio Table 94. SA Scientific Recent Development Table 95. North America Influenza Diagnostics Market Size by Type (2021-2026) & (US$ Million) Table 96. North America Influenza Diagnostics Market Size by Type (2027-2032) & (US$ Million) Table 97. North America Influenza Diagnostics Market Size by Application (2021-2026) & (US$ Million) Table 98. North America Influenza Diagnostics Market Size by Application (2027-2032) & (US$ Million) Table 99. North America Influenza Diagnostics Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 100. North America Influenza Diagnostics Market Size by Country (2021-2026) Table 101. North America Influenza Diagnostics Market Size by Country (2027-2032) Table 102. Europe Influenza Diagnostics Market Size by Type (2021-2026) & (US$ Million) Table 103. Europe Influenza Diagnostics Market Size by Type (2027-2032) & (US$ Million) Table 104. Europe Influenza Diagnostics Market Size by Application (2021-2026) & (US$ Million) Table 105. Europe Influenza Diagnostics Market Size by Application (2027-2032) & (US$ Million) Table 106. Europe Influenza Diagnostics Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 107. Europe Influenza Diagnostics Market Size by Country (2021-2026) Table 108. Europe Influenza Diagnostics Market Size by Country (2027-2032) Table 109. China Influenza Diagnostics Market Size by Type (2021-2026) & (US$ Million) Table 110. China Influenza Diagnostics Market Size by Type (2027-2032) & (US$ Million) Table 111. China Influenza Diagnostics Market Size by Application (2021-2026) & (US$ Million) Table 112. China Influenza Diagnostics Market Size by Application (2027-2032) & (US$ Million) Table 113. Asia Influenza Diagnostics Market Size by Type (2021-2026) & (US$ Million) Table 114. Asia Influenza Diagnostics Market Size by Type (2027-2032) & (US$ Million) Table 115. Asia Influenza Diagnostics Market Size by Application (2021-2026) & (US$ Million) Table 116. Asia Influenza Diagnostics Market Size by Application (2027-2032) & (US$ Million) Table 117. Asia Influenza Diagnostics Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 118. Asia Influenza Diagnostics Market Size by Country (2021-2026) Table 119. Asia Influenza Diagnostics Market Size by Country (2027-2032) Table 120. South America, Middle East & Africa Influenza Diagnostics Market Size by Type (2021-2026) & (US$ Million) Table 121. South America, Middle East & Africa Influenza Diagnostics Market Size by Type (2027-2032) & (US$ Million) Table 122. South America, Middle East & Africa Influenza Diagnostics Market Size by Application (2021-2026) & (US$ Million) Table 123. South America, Middle East & Africa Influenza Diagnostics Market Size by Application (2027-2032) & (US$ Million) Table 124. South America, Middle East & Africa Influenza Diagnostics Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 125. South America, Middle East & Africa Influenza Diagnostics Market Size by Country (2021-2026) Table 126. South America, Middle East & Africa Influenza Diagnostics Market Size by Country (2027-2032) Table 127. Research Programs/Design for This Report Table 128. Authors List of This Report Table 129. Secondary Sources Table 130. Primary Sources List of Figures Figure 1. Influenza Diagnostics Product Image Figure 2. Global Influenza Diagnostics Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Influenza Diagnostics Market Share by Type: 2025 VS 2032 Figure 4. RIDT Image Figure 5. RT-PCR Image Figure 6. Cell Culture Image Figure 7. Others Image Figure 8. Global Influenza Diagnostics Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 9. Global Influenza Diagnostics Market Share by Application: 2025 VS 2032 Figure 10. Hospitals Image Figure 11. POCT Image Figure 12. Others Image Figure 13. Global Influenza Diagnostics Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Influenza Diagnostics Market Size (2021-2032) & (US$ Million) Figure 15. Global Influenza Diagnostics Market Share by Region: 2025 VS 2032 Figure 16. Years Considered Figure 17. Global Influenza Diagnostics Market Share by Players in 2025 Figure 18. Global Top 5 and 10 Influenza Diagnostics Players Market Share by Revenue in 2025 Figure 19. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. Global Influenza Diagnostics Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Influenza Diagnostics Revenue Market Share by Type (2021-2032) Figure 22. Global Influenza Diagnostics Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Influenza Diagnostics Revenue Market Share by Application (2021-2032) Figure 24. North America Influenza Diagnostics Market Size (2021-2032) & (US$ Million) Figure 25. North America Influenza Diagnostics Market Share by Type (2021-2032) Figure 26. North America Influenza Diagnostics Market Share by Application (2021-2032) Figure 27. North America Influenza Diagnostics Market Share by Country (2021-2032) Figure 28. United States Influenza Diagnostics Market Size (2021-2032) & (US$ Million) Figure 29. Canada Influenza Diagnostics Market Size (2021-2032) & (US$ Million) Figure 30. Mexico Influenza Diagnostics Market Size (2021-2032) & (US$ Million) Figure 31. Europe Influenza Diagnostics Market Size (2021-2032) & (US$ Million) Figure 32. Europe Influenza Diagnostics Market Share by Type (2021-2032) Figure 33. Europe Influenza Diagnostics Market Share by Application (2021-2032) Figure 34. Europe Influenza Diagnostics Market Share by Country (2021-2032) Figure 35. Germany Influenza Diagnostics Market Size (2021-2032) & (US$ Million) Figure 36. France Influenza Diagnostics Market Size (2021-2032) & (US$ Million) Figure 37. U.K. Influenza Diagnostics Market Size (2021-2032) & (US$ Million) Figure 38. Italy Influenza Diagnostics Market Size (2021-2032) & (US$ Million) Figure 39. Russia Influenza Diagnostics Market Size (2021-2032) & (US$ Million) Figure 40. Nordic Countries Influenza Diagnostics Market Size (2021-2032) & (US$ Million) Figure 41. China Influenza Diagnostics Market Size (2021-2032) & (US$ Million) Figure 42. China Influenza Diagnostics Market Share by Type (2021-2032) Figure 43. China Influenza Diagnostics Market Share by Application (2021-2032) Figure 44. Asia Influenza Diagnostics Market Size (2021-2032) & (US$ Million) Figure 45. Asia Influenza Diagnostics Market Share by Type (2021-2032) Figure 46. Asia Influenza Diagnostics Market Share by Application (2021-2032) Figure 47. Asia Influenza Diagnostics Market Share by Country (2021-2032) Figure 48. Japan Influenza Diagnostics Market Size (2021-2032) & (US$ Million) Figure 49. South Korea Influenza Diagnostics Market Size (2021-2032) & (US$ Million) Figure 50. Taiwan Influenza Diagnostics Market Size (2021-2032) & (US$ Million) Figure 51. Southeast Asia Influenza Diagnostics Market Size (2021-2032) & (US$ Million) Figure 52. India Influenza Diagnostics Market Size (2021-2032) & (US$ Million) Figure 53. Australia Influenza Diagnostics Market Size (2021-2032) & (US$ Million) Figure 54. South America, Middle East & Africa Influenza Diagnostics Market Size (2021-2032) & (US$ Million) Figure 55. South America, Middle East & Africa Influenza Diagnostics Market Share by Type (2021-2032) Figure 56. South America, Middle East & Africa Influenza Diagnostics Market Share by Application (2021-2032) Figure 57. South America, Middle East & Africa Influenza Diagnostics Market Share by Country (2021-2032) Figure 58. Brazil Influenza Diagnostics Market Size (2021-2032) & (US$ Million) Figure 59. South Africa Influenza Diagnostics Market Size (2021-2032) & (US$ Million) Figure 60. Saudi Arabia Influenza Diagnostics Market Size (2021-2032) & (US$ Million) Figure 61. Turkey Influenza Diagnostics Market Size (2021-2032) & (US$ Million) Figure 62. Argentina Influenza Diagnostics Market Size (2021-2032) & (US$ Million) Figure 63. UAE Influenza Diagnostics Market Size (2021-2032) & (US$ Million) Figure 64. Egypt Influenza Diagnostics Market Size (2021-2032) & (US$ Million) Figure 65. Chile Influenza Diagnostics Market Size (2021-2032) & (US$ Million) Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • RIDT
  • RT-PCR
  • Cell Culture
  • Others
Applications
  • Hospitals
  • POCT
  • Others
Companies covered
  • BD
  • Abbott (Include Alere)
  • Roche
  • SIEMENS
  • Analytik Jena
  • Quidel
  • Thermo Fisher
  • Meridian Bioscience
  • BioMerieux
  • Sekisui Diagnostics
  • Response Biomedical
  • SA Scientific

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Influenza Diagnostics Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 RIDT
  5. 1.2.3 RT-PCR
  6. 1.2.4 Cell Culture
  7. 1.2.5 Others
  8. 1.3 Market Analysis by Application
  9. 1.3.1 Global Influenza Diagnostics Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  10. 1.3.2 Hospitals
  11. 1.3.3 POCT
  12. 1.3.4 Others
  13. 1.4 Global Market Growth Prospects
  14. 1.5 Global Influenza Diagnostics Growth Trends by Region
  15. 1.5.1 Global Influenza Diagnostics Market Size by Region: 2021 VS 2025 VS 2032
  16. 1.5.2 Influenza Diagnostics Market Size by Region (2021-2026)
  17. 1.5.3 Influenza Diagnostics Market Size by Region (2027-2032)
  18. 1.6 Assumptions and Limitations
  19. 1.7 Study Goals and Objectives
  20. 1.8 Years Considered
2 Global Influenza Diagnostics Market Dynamics
  1. 2.1 Influenza Diagnostics Industry Trends
  2. 2.2 Influenza Diagnostics Industry Drivers
  3. 2.3 Influenza Diagnostics Industry Opportunities and Challenges
  4. 2.4 Influenza Diagnostics Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Influenza Diagnostics Revenue by Company (2021-2026)
  2. 3.2 Global Influenza Diagnostics Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Influenza Diagnostics Key Company Head office and Area Served
  4. 3.4 Global Influenza Diagnostics Company, Product Type & Application
  5. 3.5 Global Influenza Diagnostics Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Influenza Diagnostics Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Influenza Diagnostics Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Influenza Diagnostics Tier 1, Tier 2, and Tier 3
4 Influenza Diagnostics Market by Type
  1. 4.1 Global Influenza Diagnostics Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Influenza Diagnostics Market Size by Type (2021-2032)
  3. 4.3 Global Influenza Diagnostics Market Size Share by Type (2021-2032)
5 Influenza Diagnostics Market by Application
  1. 5.1 Global Influenza Diagnostics Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Influenza Diagnostics Market Size by Application (2021-2032)
  3. 5.3 Global Influenza Diagnostics Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 BD
  2. 6.1.1 BD Company Information
  3. 6.1.2 BD Business Overview
  4. 6.1.3 BD Influenza Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 BD Influenza Diagnostics Product Portfolio
  6. 6.1.5 BD Recent Developments
  7. 6.2 Abbott (Include Alere)
  8. 6.2.1 Abbott (Include Alere) Company Information
  9. 6.2.2 Abbott (Include Alere) Business Overview
  10. 6.2.3 Abbott (Include Alere) Influenza Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Abbott (Include Alere) Influenza Diagnostics Product Portfolio
  12. 6.2.5 Abbott (Include Alere) Recent Developments
  13. 6.3 Roche
  14. 6.3.1 Roche Company Information
  15. 6.3.2 Roche Business Overview
  16. 6.3.3 Roche Influenza Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Roche Influenza Diagnostics Product Portfolio
  18. 6.3.5 Roche Recent Developments
  19. 6.4 SIEMENS
  20. 6.4.1 SIEMENS Company Information
  21. 6.4.2 SIEMENS Business Overview
  22. 6.4.3 SIEMENS Influenza Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 SIEMENS Influenza Diagnostics Product Portfolio
  24. 6.4.5 SIEMENS Recent Developments
  25. 6.5 Analytik Jena
  26. 6.5.1 Analytik Jena Company Information
  27. 6.5.2 Analytik Jena Business Overview
  28. 6.5.3 Analytik Jena Influenza Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Analytik Jena Influenza Diagnostics Product Portfolio
  30. 6.5.5 Analytik Jena Recent Developments
  31. 6.6 Quidel
  32. 6.6.1 Quidel Company Information
  33. 6.6.2 Quidel Business Overview
  34. 6.6.3 Quidel Influenza Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Quidel Influenza Diagnostics Product Portfolio
  36. 6.6.5 Quidel Recent Developments
  37. 6.7 Thermo Fisher
  38. 6.7.1 Thermo Fisher Company Information
  39. 6.7.2 Thermo Fisher Business Overview
  40. 6.7.3 Thermo Fisher Influenza Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Thermo Fisher Influenza Diagnostics Product Portfolio
  42. 6.7.5 Thermo Fisher Recent Developments
  43. 6.8 Meridian Bioscience
  44. 6.8.1 Meridian Bioscience Company Information
  45. 6.8.2 Meridian Bioscience Business Overview
  46. 6.8.3 Meridian Bioscience Influenza Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Meridian Bioscience Influenza Diagnostics Product Portfolio
  48. 6.8.5 Meridian Bioscience Recent Developments
  49. 6.9 BioMerieux
  50. 6.9.1 BioMerieux Company Information
  51. 6.9.2 BioMerieux Business Overview
  52. 6.9.3 BioMerieux Influenza Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 BioMerieux Influenza Diagnostics Product Portfolio
  54. 6.9.5 BioMerieux Recent Developments
  55. 6.10 Sekisui Diagnostics
  56. 6.10.1 Sekisui Diagnostics Company Information
  57. 6.10.2 Sekisui Diagnostics Business Overview
  58. 6.10.3 Sekisui Diagnostics Influenza Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Sekisui Diagnostics Influenza Diagnostics Product Portfolio
  60. 6.10.5 Sekisui Diagnostics Recent Developments
  61. 6.11 Response Biomedical
  62. 6.11.1 Response Biomedical Company Information
  63. 6.11.2 Response Biomedical Business Overview
  64. 6.11.3 Response Biomedical Influenza Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 Response Biomedical Influenza Diagnostics Product Portfolio
  66. 6.11.5 Response Biomedical Recent Developments
  67. 6.12 SA Scientific
  68. 6.12.1 SA Scientific Company Information
  69. 6.12.2 SA Scientific Business Overview
  70. 6.12.3 SA Scientific Influenza Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 SA Scientific Influenza Diagnostics Product Portfolio
  72. 6.12.5 SA Scientific Recent Developments
7 North America
  1. 7.1 North America Influenza Diagnostics Market Size (2021-2032)
  2. 7.2 North America Influenza Diagnostics Market Size by Type
  3. 7.2.1 North America Influenza Diagnostics Market Size by Type (2021-2026)
  4. 7.2.2 North America Influenza Diagnostics Market Size by Type (2027-2032)
  5. 7.2.3 North America Influenza Diagnostics Market Share by Type (2021-2032)
  6. 7.3 North America Influenza Diagnostics Market Size by Application
  7. 7.3.1 North America Influenza Diagnostics Market Size by Application (2021-2026)
  8. 7.3.2 North America Influenza Diagnostics Market Size by Application (2027-2032)
  9. 7.3.3 North America Influenza Diagnostics Market Share by Application (2021-2032)
  10. 7.4 North America Influenza Diagnostics Market Size by Country
  11. 7.4.1 North America Influenza Diagnostics Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Influenza Diagnostics Market Size by Country (2021-2026)
  13. 7.4.3 North America Influenza Diagnostics Market Size by Country (2027-2032)
  14. 7.4.4 North America Influenza Diagnostics Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Influenza Diagnostics Market Size (2021-2032)
  2. 8.2 Europe Influenza Diagnostics Market Size by Type
  3. 8.2.1 Europe Influenza Diagnostics Market Size by Type (2021-2026)
  4. 8.2.2 Europe Influenza Diagnostics Market Size by Type (2027-2032)
  5. 8.2.3 Europe Influenza Diagnostics Market Share by Type (2021-2032)
  6. 8.3 Europe Influenza Diagnostics Market Size by Application
  7. 8.3.1 Europe Influenza Diagnostics Market Size by Application (2021-2026)
  8. 8.3.2 Europe Influenza Diagnostics Market Size by Application (2027-2032)
  9. 8.3.3 Europe Influenza Diagnostics Market Share by Application (2021-2032)
  10. 8.4 Europe Influenza Diagnostics Market Size by Country
  11. 8.4.1 Europe Influenza Diagnostics Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Influenza Diagnostics Market Size by Country (2021-2026)
  13. 8.4.3 Europe Influenza Diagnostics Market Size by Country (2027-2032)
  14. 8.4.4 Europe Influenza Diagnostics Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Influenza Diagnostics Market Size (2021-2032)
  2. 9.2 China Influenza Diagnostics Market Size by Type
  3. 9.2.1 China Influenza Diagnostics Market Size by Type (2021-2026)
  4. 9.2.2 China Influenza Diagnostics Market Size by Type (2027-2032)
  5. 9.2.3 China Influenza Diagnostics Market Share by Type (2021-2032)
  6. 9.3 China Influenza Diagnostics Market Size by Application
  7. 9.3.1 China Influenza Diagnostics Market Size by Application (2021-2026)
  8. 9.3.2 China Influenza Diagnostics Market Size by Application (2027-2032)
  9. 9.3.3 China Influenza Diagnostics Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Influenza Diagnostics Market Size (2021-2032)
  2. 10.2 Asia Influenza Diagnostics Market Size by Type
  3. 10.2.1 Asia Influenza Diagnostics Market Size by Type (2021-2026)
  4. 10.2.2 Asia Influenza Diagnostics Market Size by Type (2027-2032)
  5. 10.2.3 Asia Influenza Diagnostics Market Share by Type (2021-2032)
  6. 10.3 Asia Influenza Diagnostics Market Size by Application
  7. 10.3.1 Asia Influenza Diagnostics Market Size by Application (2021-2026)
  8. 10.3.2 Asia Influenza Diagnostics Market Size by Application (2027-2032)
  9. 10.3.3 Asia Influenza Diagnostics Market Share by Application (2021-2032)
  10. 10.4 Asia Influenza Diagnostics Market Size by Country
  11. 10.4.1 Asia Influenza Diagnostics Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Influenza Diagnostics Market Size by Country (2021-2026)
  13. 10.4.3 Asia Influenza Diagnostics Market Size by Country (2027-2032)
  14. 10.4.4 Asia Influenza Diagnostics Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Influenza Diagnostics Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Influenza Diagnostics Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Influenza Diagnostics Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Influenza Diagnostics Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Influenza Diagnostics Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Influenza Diagnostics Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Influenza Diagnostics Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Influenza Diagnostics Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Influenza Diagnostics Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Influenza Diagnostics Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Influenza Diagnostics Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Influenza Diagnostics Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Influenza Diagnostics Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Influenza Diagnostics Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst